Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention [Original Articles]
Lee, C. R., Sriramoju, V. B., Cervantes, A., Howell, L. A., Varunok, N., Madan, S., Hamrick, K., Polasek, M. J., Lee, J. A., Clarke, M., Cicci, J. D., Weck, K. E., Stouffer, G. A.
American Heart Association (AHA)
Published 2018
American Heart Association (AHA)
Published 2018
| Publication Date: |
2018-04-04
|
|---|---|
| Publisher: |
American Heart Association (AHA)
|
| Print ISSN: |
1942-325X
|
| Electronic ISSN: |
1942-3268
|
| Topics: |
Medicine
|
| Keywords: |
Genetics, Pharmacology, Acute Coronary Syndromes, Atherosclerosis
|
| Published by: |